Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;68(4):271-281.
doi: 10.1007/s00105-017-3958-8.

[Molecular-allergological aspects of allergen-specific immunotherapy]

[Article in German]
Uta Jappe  1   2
Affiliations
Review

[Molecular-allergological aspects of allergen-specific immunotherapy]

[Article in German]
Uta Jappe. Hautarzt. 2017 Apr.

Abstract

Allergen-specific immunotherapy (SIT) does not achieve 100% efficacy, nor is there a reliable marker for therapy failure. However, advances in molecular allergology over the past few years have allowed a significantly improved characterization of the patients using molecular-allergological analysis methods (molecular phenotyping). Thus, major and minor allergens can be identified. In addition, the marker allergens for the severity of an allergic reaction, the pathological and therapeutic predictive marker allergens, and sensitization patterns are identified.

Keywords: Biomarker; Desensitization, immunologic; Major allergens; Marker allergens; Minor allergens.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hautarzt. 2010 Nov;61(11):946-53 - PubMed
    1. Eur Ann Allergy Clin Immunol. 2012 Oct;44(5):183-7 - PubMed
    1. Allergy. 2007 Jul;62(7):729-32 - PubMed
    1. Clin Mol Allergy. 2010 Apr 01;8:7 - PubMed
    1. Allergy. 2015 Jan;70(1):90-8 - PubMed

LinkOut - more resources